window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Drug Development

    Lubrizol hits clinical milestone with novel solubility-enhancing excipient

    Apisolex polymer excipient formulation enters Phase 1 trials, supporting delivery [...]

    June 23, 2025
  • Cell & Gene Therapy,Clinical Trials,Drug Development

    Novadip’s autologous cell therapy NVD003 receives RMAT designation for rare pediatric bone disorder

    FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]

    June 23, 2025
  • Clinical Trials,Drug Development

    EC approves ADCETRIS-based BrECADD regimen for newly diagnosed advanced Hodgkin lymphoma

    Takeda’s antibody-drug conjugate gains second frontline indication following positive Phase [...]

    June 23, 2025
  • CDMOs & Manufacturing,Drug Development

    As BIO International 2025 closes – Discover Pharma captures voices shaping pharma’s next chapter

    As the global biopharma industry gathered at BIO International in [...]

    June 20, 2025
  • Drug Delivery & Formulation,Drug Development

    Bio-Rad expands antibody and SpyCatcher ranges to support drug development and bioanalysis

    Bio-Rad Laboratories has introduced five new recombinant monoclonal anti-idiotypic antibodies [...]

    June 20, 2025
  • Drug Delivery & Formulation,Drug Development,Precision medicine

    UK poised to lead in functional genomics, BIA says

    The BioIndustry Association (BIA) has released a new explainer highlighting [...]

    June 13, 2025
  • Drug Development,Precision medicine

    Elkedonia raises EUR 11.25 million to develop new treatment for depression and other neuropsychiatric disorders

    New approach targets Elk1 to restore neuroplasticity without sedation or [...]

    June 12, 2025
  • Drug Development

    CN Bio expands liver-on-a-chip platform to include cross-species DILI models, enhancing IVIVE insights

    CN Bio has introduced two new animal-derived liver-on-a-chip models to [...]

    June 10, 2025
  • Drug Development

    Study shows bifunctional immunotherapy clears MDR Gram-negative bacteria in preclinical models

    CTX-09 demonstrates immune-mediated efficacy through Alphamer platform, supporting immune system [...]

    June 10, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Drug Development,Partnerships & Funding

    Axio and Likarda team up to streamline biologic drug delivery and manufacturing

    Axio BioPharma and Likarda have announced a strategic collaboration designed [...]

    June 10, 2025
Previous202122Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • UK science commercialisation faces structural gaps beyond funding, industry warns
    Categories: Research & Development
  • Inflammation linked to bone loss in aggressive childhood leukemia
    Categories: Hematology, Oncology, Research & Development
  • FoRx Therapeutics presents preclinical data on PARG inhibitor FORX-428 at ACS Spring 2026
    Categories: Clinical Development, Drug discovery, Oncology, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top